Metformin for Weight Loss in PCOS

Weight Loss Efficacy

Metformin produces minimal weight loss compared to other interventions, with a mean weight reduction of approximately 3.9 kg in women with PCOS and overweight BMI, but this modest benefit is undermined by extremely poor adherence, with only 22% of patients continuing therapy for the intended 5-year follow-up period 1, 2
The 2023 International Evidence-based Guideline recommends metformin as an adjunct to lifestyle management with a focus on prevention of weight gain rather than active weight loss 3

Bariatric surgery produces mean weight loss of 30.03 kg and BMI reduction of 11.29 kg/m² in women with PCOS, representing approximately 10-fold greater weight loss than metformin 2
GLP-1 receptor agonists are emerging as superior alternatives for weight reduction in PCOS, particularly when combined with metformin 4, 5

Metformin is recommended for women with PCOS who demonstrate insulin resistance or metabolic syndrome features, regardless of normal HbA1c values, as it improves insulin sensitivity and reduces cardiovascular risk factors 4
The American College of Obstetricians and Gynecologists (ACOG) supports metformin use to improve insulin sensitivity, which decreases circulating androgens and may normalize ovulatory abnormalities 4
Typical effective dosing is 1500-2000 mg daily, with treatment duration of at least 12 weeks needed to assess metabolic and hormonal response 4, 6

Add metformin 1500-2000 mg daily if insulin resistance or metabolic syndrome features are present, understanding it provides only subtle additive effect on weight but offers important metabolic and reproductive benefits 1, 4
Consider GLP-1 receptor agonists for inadequate response to metformin, as these provide superior weight reduction and metabolic benefits 4, 5
Refer for bariatric surgery evaluation in women with BMI ≥35 kg/m² who fail pharmacotherapy, as surgery produces 30 kg average weight loss versus 3-4 kg with metformin 1, 2

Renal function must be adequate (eGFR ≥30 mL/min/1.73m²), as metformin is absolutely contraindicated in renal impairment 5, 6
Exclude hepatic disease, severe infections, hypoxemic conditions, and alcohol abuse, all of which contraindicate metformin use 4, 6
Discontinue metformin temporarily during acute illness with dehydration/hypoxemia and with radiocontrast material administration 4, 6
Provide contraception counseling, as metformin may restore ovulation unpredictably, increasing risk of unplanned pregnancy before optimal metabolic control is achieved 4, 5